Home/Filings/4/0001127602-24-017674
4//SEC Filing

Girshick Birgit 4

Accession 0001127602-24-017674

CIK 0001100682other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:21 PM ET

Size

7.1 KB

Accession

0001127602-24-017674

Insider Transaction Report

Form 4
Period: 2024-05-31
Girshick Birgit
Corporate Executive VP & COO
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-05-31$208.44/sh+8,722$1,818,0148,722 total
    Exercise: $208.44From: 2025-05-31Exp: 2034-05-31Common Stock (8,722 underlying)
  • Award

    Common Stock

    2024-05-31+3,83850,512 total
Footnotes (2)
  • [F1]Unvested restricted stock units vest as follows: 959 on May 31, 2025, 960 on May 31, 2026, 959 on May 31, 2027, and 960 on May 31, 2028.
  • [F2]Stock options vest as follows: 2,180 on May 31, 2025, 2,181 on May 31, 2026, 2,180 on May 31, 2027, and 2,181 on May 31, 2028.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1
  • filerCIK 0001732091

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:21 PM ET
Size
7.1 KB